Mete T, Yalcin Y, Berker D, et al
*Clinical Trial Reported by 'Medicube AGE-R Gluatathione Glow Toner human application test report'
doi: 10.3389/fmed.2025.1643415 Received 08 June 2025 Accepted 25 September 2025 Published 14 October 2025 Volume 12 - 2025 Edited by Xin Hu, National Center for Child Health and Development (NCCHD), Japan Reviewed by Hua Miao, Northwest University, China Allan Kardec Barros, Universidade Federal do Maranho, Brazil ChandraShekar Annamalai, MVM College of Allied Health Sciences, India Updates Copyright 2025 Wang, Yuan, Wu and Ou
Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization
The beneficial effects of GLP-1 RAs on HRQoL and other outcomes in HFpEF are likely due to pleiotropic impacts, related or not to weight reduction, such as decongestion (mainly due to the reduction of increased plasma volume associated with obesity and epicardial constrain), reverse cardiac remodelling (mainly due to the decrease in epicardial fat and regression of left atrial and LV myopathy, lowering intracardiac pressure) and anti-inflammatory actions, among others
Stage IV The cancer has progressed to other regions of the body, such as the liver, at stage IV
